Glycemic Control: advantage goes to CagriSema
Important: We strongly advise against IV glutathione therapy during pregnancy unless specifically directed and supervised by a medical doctor in a clinical setting
While most patients tolerate B12 shots well, mild side effects can occasionally occur, including minor pain or redness at the injection site, mild diarrhoea, or, in rare instances, an allergic reaction
The 2025 studys strong method gives a clearer picture than some older studies
The estimated mean change in body weight at week 68 was 20.4% with CagriSema versus 3.0% with placebo (a difference of about 17 percentage points), and more CagriSema participants reached weight-loss thresholds of 5%, 20%, 25%, and 30% than placebo
Your plea for help will no longer fall on deaf ears